|
Engineering Triggered Nanomechanical Therapeutics
|
5R01CA140759-05
|
$303,525
|
$91,058
|
PIERCE, NILES
|
CALIFORNIA INSTITUTE OF TECHNOLOGY
|
|
Cancer Center Support Grant
|
3P30CA023108-35S1
|
$12,500
|
$250
|
ISRAEL, MARK
|
DARTMOUTH COLLEGE
|
|
Cancer Center Support Grant
|
3P30CA023108-35S2
|
$50,000
|
$1,000
|
ISRAEL, MARK
|
DARTMOUTH COLLEGE
|
|
Cancer Center Support Grant
|
5P30CA023108-35
|
$2,922,577
|
$58,452
|
ISRAEL, MARK
|
DARTMOUTH COLLEGE
|
|
Mechanisms of concomitant tumor immunity and autoimmunity
|
5R01CA120777-07
|
$201,886
|
$201,886
|
Turk, Mary
|
DARTMOUTH COLLEGE
|
|
Cadherin11 in cancer & rheumatoid arthritis: Common target, common therapies? (5)
|
5R01CA170653-02
|
$550,881
|
$137,720
|
BYERS, STEPHEN
|
GEORGETOWN UNIVERSITY
|
|
Georgetown University, Lombardi Cancer Center Support Grant Competitive Renewal
|
3P30CA051008-20S1
|
$43,750
|
$438
|
WEINER, LOUIS
|
GEORGETOWN UNIVERSITY
|
|
Georgetown University, Lombardi Cancer Center Support Grant Competitive Renewal
|
5P30CA051008-20
|
$1,449,710
|
$14,497
|
WEINER, LOUIS
|
GEORGETOWN UNIVERSITY
|
|
Statins & Lymphoid Malignancy Risk in a Large Multi-Site Population-Based Cohort
|
5R01CA140754-04
|
$523,362
|
$523,362
|
Johnson, Christine C
|
HENRY FORD HEALTH SYSTEM
|
|
Egr-2/3 and NAB2 in T Cell Anergy and Activation
|
5R01CA098109-09
|
$257,775
|
$64,444
|
POWELL, JONATHAN
|
JOHNS HOPKINS UNIVERSITY
|
|
Endogenous Nitrite Carcinogenesis in Man
|
5P01CA026731-34
|
$1,642,348
|
$82,117
|
Tannenbaum, Steven
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
Cancer Risk: Advancing knowledge in systemic rheumatic disease
|
1R03CA173822-01A1
|
$70,167
|
$70,167
|
Bernatsky, Sasha
|
MCGILL UNIVERSITY HEALTH CTR RES INST
|
|
TGF Beta-Induced Apoptosis in B-Lymphocytes
|
5R01CA080095-16
|
$253,908
|
$253,908
|
HOWE, PHILIP
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
Medical University of South Carolina - Cancer Center Support Grant
|
3P30CA138313-05S1
|
$34,031
|
$681
|
Kraft, Andrew
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
Medical University of South Carolina - Cancer Center Support Grant
|
5P30CA138313-05
|
$1,310,169
|
$26,203
|
KRAFT, ANDREW
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
Clinical Cancer Cytogenetics
|
ZID BC 010694
|
$582,141
|
$29,107
|
Arthur, Diane
|
CCR (NCI)
|
|
T Cell Alternative p38 Activation Pathway
|
ZIA BC 010774
|
$263,161
|
$263,161
|
Ashwell, Jonathan
|
CCR (NCI)
|
|
Regulation and Consequences of Ubiquitination
|
ZIA BC 010779
|
$263,161
|
$52,632
|
Ashwell, Jonathan
|
CCR (NCI)
|
|
Glucocorticoids and T cell development and function
|
ZIA BC 011264
|
$263,161
|
$263,161
|
Ashwell, Jonathan
|
CCR (NCI)
|
|
Multiple Myeloma - Yale case-control
|
ZIA CP010123-02380
|
$58,022
|
$2,901
|
Baris, Dalsu
|
DCEG (NCI)
|
|
Molecular Mechanism of Action of Phorbol Ester
|
ZIA BC 005270
|
$1,306,961
|
$196,044
|
Blumberg, Peter
|
CCR (NCI)
|
|
Mechanisms of Viral Fusion and Inactivation
|
ZIA BC 008303
|
$228,937
|
$11,447
|
Blumenthal, Robert
|
CCR (NCI)
|
|
Families at high risk of cancer
|
ZIA CP004410-08285
|
$1,048,784
|
$157,318
|
Caporaso, Neil
|
DCEG (NCI)
|
|
Familial aspects of Waldenstrom's macroglobulinemia
|
ZIA CP004410-08300
|
$221,232
|
$66,370
|
Caporaso, Neil
|
DCEG (NCI)
|
|
Effects of genetic polymorphism in MHC, KIR, and related loci on human disease
|
ZIA BC 010791
|
$721,737
|
$108,260
|
Carrington, Mary
|
CCR (NCI)
|
|
Cytokines and T Cell Development
|
ZIA BC 009287
|
$456,070
|
$91,214
|
Durum, Scott
|
CCR (NCI)
|
|
Registry linkage projects [including Scandinavia, SEER Medicare, other]
|
ZIA CP010150-10359
|
$158,182
|
$15,818
|
Engels, Eric
|
DCEG (NCI)
|
|
Diet and obesity related exposures in SEER-Medicare
|
ZIA CP010127-10573
|
$44,044
|
$2,202
|
Freedman, Neal
|
DCEG (NCI)
|
|
Historical HIV/AIDS and pilot studies
|
ZIA CP010214-10106
|
$66,117
|
$6,612
|
Goedert, Jim
|
DCEG (NCI)
|
|
Familial case-control study of lymphoproliferative malignancies and auto-immune d
|
ZIA CP005803-00355
|
$37,062
|
$37,062
|
Goldin, Lynn
|
DCEG (NCI)
|
|
Xenobiotic Receptors
|
ZIA BC 005708
|
$707,692
|
$212,308
|
Gonzalez, Frank
|
CCR (NCI)
|
|
ETIB Clinical Research Core
|
ZID BC 010963
|
$1,624,711
|
$324,942
|
Gress, Ronald
|
CCR (NCI)
|
|
Immune reconstitution following autologous and allogeneic stem cell transplant
|
ZIC BC 010934
|
$584,855
|
$175,456
|
Hakim, Frances
|
CCR (NCI)
|
|
The Role of T Cell Avidity in Determining Tumor Immunity and Autoimmunity
|
ZIA BC 010955
|
$407,615
|
$81,523
|
Hurwitz, Arthur
|
CCR (NCI)
|
|
Hematopathology Diagnosis
|
ZIA BC 011070
|
$401,053
|
$80,211
|
Jaffe, Elaine
|
CCR (NCI)
|
|
Immunopathologic Mechanisms Involved in Inflammatory Skin Diseases
|
ZIA SC 003657
|
$565,971
|
$424,478
|
Katz, Stephen
|
CCR (NCI)
|
|
Histology Core Laboratory
|
ZIC BC 010687
|
$944,029
|
$75,522
|
Kleiner, David
|
CCR (NCI)
|
|
Mechanism of action and therapeutic utility of immunosuppressive oligonucleotide
|
ZIA BC 010853
|
$259,080
|
$51,816
|
Klinman, Dennis
|
CCR (NCI)
|
|
Role of T-bet in the pathogenesis of experimental autoimmune encephalomyelitis
|
ZIA BC 011431
|
$256,398
|
$153,839
|
Lazarevic, Vanja
|
CCR (NCI)
|
|
Regulation of T-bet expression in TH17 cells by microRNAs
|
ZIA BC 011432
|
$256,398
|
$128,199
|
Lazarevic, Vanja
|
CCR (NCI)
|
|
Vascular Biology in Cancer
|
ZIA BC 011390
|
$1,345,130
|
$67,257
|
Lin, Pengnian Charles
|
CCR (NCI)
|
|
TNF Signaling and Cell Death
|
ZIA SC 010376
|
$736,598
|
$73,660
|
Liu, Zheng-Gang
|
CCR (NCI)
|
|
Cancer risk among Japanese A-bomb survivors
|
ZIA CP010134-04016
|
$412,577
|
$82,515
|
Mabuchi, Kiyohiko
|
DCEG (NCI)
|
|
Biology and Therapy of Lymphopenia
|
ZIA BC 011069
|
$368,049
|
$220,829
|
Mackall, Crystal
|
CCR (NCI)
|
|
Veterans Administration hospitalization database, Patient Treatment File, and Out
|
ZIA CP010126-00580
|
$52,897
|
$13,224
|
McGlynn, Katherine
|
DCEG (NCI)
|
|
Signal Transduction of Paired Inhibitory Receptors of NK Cells and Macrophages
|
ZIA BC 010300
|
$588,689
|
$58,869
|
McVicar, Daniel
|
CCR (NCI)
|
|
Nitroxides as Protectors Against Oxidative Stress
|
ZIA SC 006387
|
$389,114
|
$194,557
|
Mitchell, James
|
CCR (NCI)
|
|
Cell-free assay technologies for the identification of active compounds
|
ZIA BC 011471
|
$583,633
|
$192,599
|
O'Keefe, Barry
|
CCR (NCI)
|
|
Conditional manipulation of hnRNPLL expression in murine models
|
ZIA BC 011294
|
$72,123
|
$18,031
|
Oberdoerffer, Shalini
|
CCR (NCI)
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,287,528
|
$64,376
|
Oberholtzer, J.
|
CCR (NCI)
|
Total relevant funding to Autoimmune Diseases for this search: $8,954,025
|